1fpv › Citations

Structure determination of feline panleukopenia virus empty particles.

Agbandje M, McKenna R, Rossmann MG, Strassheim ML, Parrish CR
Proteins 16 155-71 (1993)
Cited: 116 times
EuropePMC logo PMID: 8392729

Abstract

Various crystal forms of the single-stranded DNA, feline panleukopenia virus (FPV), a parvovirus, have been grown of both full virions and empty particles. The structure of empty particles crystallized in an orthorhombic space group P2(1)2(1)2(1), with unit cell dimensions a = 380.1 A, b = 379.3 A, and c = 350.9 A, has been determined to 3.3 A resolution. The data were collected using oscillation photography with synchrotron radiation. The orientations of the empty capsids in the unit cell were determined using a self-rotation function and their positions were obtained with an R-factor search using canine parvovirus (CPV) as a model. Phases were then calculated, based on the CPV model, to 6.0 A resolution and gradually extended to 3.3 A resolution by molecular replacement electron density averaging. The resultant electron density was readily interpreted in terms of the known amino acid sequence. The structure is contrasted to that of CPV in terms of host range, neutralization by antibodies, hemagglutination properties, and binding of genomic DNA.

Reviews - 1fpv mentioned but not cited (1)

  1. Twenty-Five Years of Structural Parvovirology. Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Viruses 11 E362 (2019)

Articles - 1fpv mentioned but not cited (4)

  1. Structural comparison of different antibodies interacting with parvovirus capsids. Hafenstein S, Bowman VD, Sun T, Nelson CD, Palermo LM, Chipman PR, Battisti AJ, Parrish CR, Rossmann MG. J Virol 83 5556-5566 (2009)
  2. Single Mutations in the VP2 300 Loop Region of the Three-Fold Spike of the Carnivore Parvovirus Capsid Can Determine Host Range. Allison AB, Organtini LJ, Zhang S, Hafenstein SL, Holmes EC, Parrish CR. J Virol 90 753-767 (2016)
  3. The structure and host entry of an invertebrate parvovirus. Meng G, Zhang X, Plevka P, Yu Q, Tijssen P, Rossmann MG. J Virol 87 12523-12530 (2013)
  4. Feline Panleukopenia Virus With G299E Substitution in the VP2 Protein First Identified From a Captive Giant Panda in China. Yi S, Liu S, Meng X, Huang P, Cao Z, Jin H, Wang J, Hu G, Lan J, Zhang D, Gao Y, Wang H, Li N, Feng N, Hou R, Yang S, Xia X. Front Cell Infect Microbiol 11 820144 (2021)


Reviews citing this publication (17)

  1. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Parrish CR, Kawaoka Y. Annu Rev Microbiol 59 553-586 (2005)
  2. Parvovirus host range, cell tropism and evolution. Hueffer K, Parrish CR. Curr Opin Microbiol 6 392-398 (2003)
  3. AAV hybrid serotypes: improved vectors for gene delivery. Choi VW, McCarty DM, Samulski RJ. Curr Gene Ther 5 299-310 (2005)
  4. Receptor targeting of adeno-associated virus vectors. Büning H, Ried MU, Perabo L, Gerner FM, Huttner NA, Enssle J, Hallek M. Gene Ther 10 1142-1151 (2003)
  5. How do animal DNA viruses get to the nucleus? Kasamatsu H, Nakanishi A. Annu Rev Microbiol 52 627-686 (1998)
  6. Adeno-associated virus vectors: potential applications for cancer gene therapy. Li C, Bowles DE, van Dyke T, Samulski RJ. Cancer Gene Ther 12 913-925 (2005)
  7. Host range relationships and the evolution of canine parvovirus. Parrish CR. Vet Microbiol 69 29-40 (1999)
  8. Parvovirus glycan interactions. Huang LY, Halder S, Agbandje-McKenna M. Curr Opin Virol 7 108-118 (2014)
  9. Pathogenesis of feline panleukopenia virus and canine parvovirus. Parrish CR. Baillieres Clin Haematol 8 57-71 (1995)
  10. Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy. Virag T, Cecchini S, Kotin RM. Hum Gene Ther 20 807-817 (2009)
  11. Structure of viruses: a short history. Rossmann MG. Q Rev Biophys 46 133-180 (2013)
  12. Pathways of cell infection by parvoviruses and adeno-associated viruses. Vihinen-Ranta M, Suikkanen S, Parrish CR. J Virol 78 6709-6714 (2004)
  13. Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family. Emmanuel SN, Mietzsch M, Tseng YS, Smith JK, Agbandje-McKenna M. Viral Immunol 34 3-17 (2021)
  14. Small but mighty: old and new parvoviruses of veterinary significance. Jager MC, Tomlinson JE, Lopez-Astacio RA, Parrish CR, Van de Walle GR. Virol J 18 210 (2021)
  15. Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry. Large EE, Silveria MA, Zane GM, Weerakoon O, Chapman MS. Viruses 13 1336 (2021)
  16. Structural studies on antibody recognition and neutralization of viruses. Smith TJ. Curr Opin Virol 1 150-156 (2011)
  17. The Structures and Functions of Parvovirus Capsids and Missing Pieces: the Viral DNA and Its Packaging, Asymmetrical Features, Nonprotein Components, and Receptor or Antibody Binding and Interactions. López-Astacio RA, Adu OF, Lee H, Hafenstein SL, Parrish CR. J Virol 97 e0016123 (2023)

Articles citing this publication (94)

  1. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS. Proc Natl Acad Sci U S A 99 10405-10410 (2002)
  2. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. Wu P, Xiao W, Conlon T, Hughes J, Agbandje-McKenna M, Ferkol T, Flotte T, Muzyczka N. J Virol 74 8635-8647 (2000)
  3. The structure of simian virus 40 refined at 3.1 A resolution. Stehle T, Gamblin SJ, Yan Y, Harrison SC. Structure 4 165-182 (1996)
  4. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. Hueffer K, Parker JS, Weichert WS, Geisel RE, Sgro JY, Parrish CR. J Virol 77 1718-1726 (2003)
  5. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Grifman M, Trepel M, Speece P, Gilbert LB, Arap W, Pasqualini R, Weitzman MD. Mol Ther 3 964-975 (2001)
  6. Functional implications of the structure of the murine parvovirus, minute virus of mice. Agbandje-McKenna M, Llamas-Saiz AL, Wang F, Tattersall P, Rossmann MG. Structure 6 1369-1381 (1998)
  7. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. Truyen U, Gruenberg A, Chang SF, Obermaier B, Veijalainen P, Parrish CR. J Virol 69 4702-4710 (1995)
  8. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. Bleker S, Sonntag F, Kleinschmidt JA. J Virol 79 2528-2540 (2005)
  9. Structure of the Maize streak virus geminate particle. Zhang W, Olson NH, Baker TS, Faulkner L, Agbandje-McKenna M, Boulton MI, Davies JW, McKenna R. Virology 279 471-477 (2001)
  10. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. Vihinen-Ranta M, Wang D, Weichert WS, Parrish CR. J Virol 76 1884-1891 (2002)
  11. The structure of porcine parvovirus: comparison with related viruses. Simpson AA, Hébert B, Sullivan GM, Parrish CR, Zádori Z, Tijssen P, Rossmann MG. J Mol Biol 315 1189-1198 (2002)
  12. The structure of human parvovirus B19. Kaufmann B, Simpson AA, Rossmann MG. Proc Natl Acad Sci U S A 101 11628-11633 (2004)
  13. Inactivation of parvovirus B19 during pasteurization of human serum albumin. Blümel J, Schmidt I, Willkommen H, Löwer J. Transfusion 42 1011-1018 (2002)
  14. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Rabinowitz JE, Xiao W, Samulski RJ. Virology 265 274-285 (1999)
  15. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. Langeveld JP, Casal JI, Osterhaus AD, Cortés E, de Swart R, Vela C, Dalsgaard K, Puijk WC, Schaaper WM, Meloen RH. J Virol 68 4506-4513 (1994)
  16. Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. Suikkanen S, Aaltonen T, Nevalainen M, Välilehto O, Lindholm L, Vuento M, Vihinen-Ranta M. J Virol 77 10270-10279 (2003)
  17. Release of canine parvovirus from endocytic vesicles. Suikkanen S, Antila M, Jaatinen A, Vihinen-Ranta M, Vuento M. Virology 316 267-280 (2003)
  18. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Chipman PR, Agbandje-McKenna M, Kajigaya S, Brown KE, Young NS, Baker TS, Rossmann MG. Proc Natl Acad Sci U S A 93 7502-7506 (1996)
  19. Assaying for structural variation in the parvovirus capsid and its role in infection. Weichert WS, Parker JS, Wahid AT, Chang SF, Meier E, Parrish CR. Virology 250 106-117 (1998)
  20. The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 A resolution. Simpson AA, Chipman PR, Baker TS, Tijssen P, Rossmann MG. Structure 6 1355-1367 (1998)
  21. Structure of adeno-associated virus type 4. Padron E, Bowman V, Kaludov N, Govindasamy L, Levy H, Nick P, McKenna R, Muzyczka N, Chiorini JA, Baker TS, Agbandje-McKenna M. J Virol 79 5047-5058 (2005)
  22. Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Reguera J, Carreira A, Riolobos L, Almendral JM, Mateu MG. Proc Natl Acad Sci U S A 101 2724-2729 (2004)
  23. Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. Hueffer K, Govindasamy L, Agbandje-McKenna M, Parrish CR. J Virol 77 10099-10105 (2003)
  24. Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. Kontou M, Govindasamy L, Nam HJ, Bryant N, Llamas-Saiz AL, Foces-Foces C, Hernando E, Rubio MP, McKenna R, Almendral JM, Agbandje-McKenna M. J Virol 79 10931-10943 (2005)
  25. The structure of a neutralized virus: canine parvovirus complexed with neutralizing antibody fragment. Wikoff WR, Wang G, Parrish CR, Cheng RH, Strassheim ML, Baker TS, Rossmann MG. Structure 2 595-607 (1994)
  26. Asymmetric binding of transferrin receptor to parvovirus capsids. Hafenstein S, Palermo LM, Kostyuchenko VA, Xiao C, Morais MC, Nelson CD, Bowman VD, Battisti AJ, Chipman PR, Parrish CR, Rossmann MG. Proc Natl Acad Sci U S A 104 6585-6589 (2007)
  27. High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. Taube S, Rubin JR, Katpally U, Smith TJ, Kendall A, Stuckey JA, Wobus CE. J Virol 84 5695-5705 (2010)
  28. Role of multiple hosts in the cross-species transmission and emergence of a pandemic parvovirus. Allison AB, Harbison CE, Pagan I, Stucker KM, Kaelber JT, Brown JD, Ruder MG, Keel MK, Dubovi EJ, Holmes EC, Parrish CR. J Virol 86 865-872 (2012)
  29. Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles. Hernando E, Llamas-Saiz AL, Foces-Foces C, McKenna R, Portman I, Agbandje-McKenna M, Almendral JM. Virology 267 299-309 (2000)
  30. Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. McKenna R, Olson NH, Chipman PR, Baker TS, Booth TF, Christensen J, Aasted B, Fox JM, Bloom ME, Wolfinbarger JB, Agbandje-McKenna M. J Virol 73 6882-6891 (1999)
  31. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. Vihinen-Ranta M, Yuan W, Parrish CR. J Virol 74 4853-4859 (2000)
  32. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. López-Bueno A, López-Bueno A, Rubio MP, Bryant N, McKenna R, Agbandje-McKenna M, Almendral JM. J Virol 80 1563-1573 (2006)
  33. In vitro disassembly of a parvovirus capsid and effect on capsid stability of heterologous peptide insertions in surface loops. Carreira A, Menéndez M, Reguera J, Almendral JM, Mateu MG. J Biol Chem 279 6517-6525 (2004)
  34. Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. Palermo LM, Hueffer K, Parrish CR. J Virol 77 8915-8923 (2003)
  35. Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants. Govindasamy L, Hueffer K, Parrish CR, Agbandje-McKenna M. J Virol 77 12211-12221 (2003)
  36. Intracellular route of canine parvovirus entry. Vihinen-Ranta M, Kalela A, Mäkinen P, Kakkola L, Marjomäki V, Vuento M. J Virol 72 802-806 (1998)
  37. Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production. Bowles DE, Rabinowitz JE, Samulski RJ. J Virol 77 423-432 (2003)
  38. Purified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host ranges. Palermo LM, Hafenstein SL, Parrish CR. J Virol 80 8482-8492 (2006)
  39. Nonstructural protein-2 and the replication of canine parvovirus. Wang D, Yuan W, Davis I, Parrish CR. Virology 240 273-281 (1998)
  40. Structural analysis of the Spiroplasma virus, SpV4: implications for evolutionary variation to obtain host diversity among the Microviridae. Chipman PR, Agbandje-McKenna M, Renaudin J, Baker TS, McKenna R. Structure 6 135-145 (1998)
  41. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. Casal JI, Langeveld JP, Cortés E, Schaaper WW, van Dijk E, Vela C, Kamstrup S, Meloen RH. J Virol 69 7274-7277 (1995)
  42. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. Grieger JC, Johnson JS, Gurda-Whitaker B, Agbandje-McKenna M, Samulski RJ. J Virol 81 7833-7843 (2007)
  43. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies. Nelson CD, Palermo LM, Hafenstein SL, Parrish CR. Virology 361 283-293 (2007)
  44. The role of evolutionary intermediates in the host adaptation of canine parvovirus. Stucker KM, Pagan I, Cifuente JO, Kaelber JT, Lillie TD, Hafenstein S, Holmes EC, Parrish CR. J Virol 86 1514-1521 (2012)
  45. Canine parvovirus capsid assembly and differences in mammalian and insect cells. Yuan W, Parrish CR. Virology 279 546-557 (2001)
  46. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Langeveld JP, Casal JI, Cortés E, van de Wetering G, Boshuizen RS, Schaaper WM, Dalsgaard K, Meloen RH. Vaccine 12 1473-1480 (1994)
  47. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability. Ros C, Baltzer C, Mani B, Kempf C. Virology 345 137-147 (2006)
  48. Visualization of the externalized VP2 N termini of infectious human parvovirus B19. Kaufmann B, Chipman PR, Kostyuchenko VA, Modrow S, Rossmann MG. J Virol 82 7306-7312 (2008)
  49. Phosphorylation status of the parvovirus minute virus of mice particle: mapping and biological relevance of the major phosphorylation sites. Maroto B, Ramírez JC, Almendral JM. J Virol 74 10892-10902 (2000)
  50. Large-scale production, purification and crystallization of wild-type adeno-associated virus-2. Xie Q, Hare J, Turnigan J, Chapman MS. J Virol Methods 122 17-27 (2004)
  51. Limited transferrin receptor clustering allows rapid diffusion of canine parvovirus into clathrin endocytic structures. Cureton DK, Harbison CE, Cocucci E, Parrish CR, Kirchhausen T. J Virol 86 5330-5340 (2012)
  52. Surface loop dynamics in adeno-associated virus capsid assembly. DiPrimio N, Asokan A, Govindasamy L, Agbandje-McKenna M, Samulski RJ. J Virol 82 5178-5189 (2008)
  53. Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking. Harbison CE, Lyi SM, Weichert WS, Parrish CR. J Virol 83 10504-10514 (2009)
  54. Structure of Penaeus stylirostris densovirus, a shrimp pathogen. Kaufmann B, Bowman VD, Li Y, Szelei J, Waddell PJ, Tijssen P, Rossmann MG. J Virol 84 11289-11296 (2010)
  55. Binding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection. Goodman LB, Lyi SM, Johnson NC, Cifuente JO, Hafenstein SL, Parrish CR. J Virol 84 4969-4978 (2010)
  56. Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid. Löfling J, Lyi SM, Parrish CR, Varki A. Virology 440 89-96 (2013)
  57. Genome characterization of a novel porcine bocavirus. Yang WZ, Yu JM, Li JS, Cheng WX, Huang CP, Duan ZJ. Arch Virol 157 2125-2132 (2012)
  58. Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Yuan W, Parrish CR. Virology 269 471-480 (2000)
  59. Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus. Horiuchi M, Yamaguchi Y, Gojobori T, Mochizuki M, Nagasawa H, Toyoda Y, Ishiguro N, Shinagawa M. Virology 249 440-452 (1998)
  60. Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells. Gilbert L, Toivola J, Lehtomäki E, Donaldson L, Käpylä P, Vuento M, Oker-Blom C. Biochem Biophys Res Commun 313 878-887 (2004)
  61. Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. Hueffer K, Palermo LM, Parrish CR. J Virol 78 5601-5611 (2004)
  62. Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids. Halder S, Nam HJ, Govindasamy L, Vogel M, Dinsart C, Salomé N, McKenna R, Agbandje-McKenna M. J Virol 87 5128-5140 (2013)
  63. Molecular epidemiology of canine parvovirus type 2 in Vietnam from November 2016 to February 2018. Hoang M, Lin WH, Le VP, Nga BTT, Chiou MT, Lin CN. Virol J 16 52 (2019)
  64. Molecular typing of a novel canine parvovirus type 2a mutant circulating in Italy. Mira F, Dowgier G, Purpari G, Vicari D, Di Bella S, Macaluso G, Gucciardi F, Randazzo V, Decaro N, Guercio A. Infect Genet Evol 61 67-73 (2018)
  65. Proteolytic mapping of the adeno-associated virus capsid. Van Vliet K, Blouin V, Agbandje-McKenna M, Snyder RO. Mol Ther 14 809-821 (2006)
  66. Complex and Dynamic Interactions between Parvovirus Capsids, Transferrin Receptors, and Antibodies Control Cell Infection and Host Range. Callaway HM, Welsch K, Weichert W, Allison AB, Hafenstein SL, Huang K, Iketani S, Parrish CR. J Virol 92 e00460-18 (2018)
  67. Epitope mapping of a monoclonal antibody specific to feline panleukopenia virus and mink enteritis virus. Horiuchi M, Mochizuki M, Ishiguro N, Nagasawa H, Shinagawa M. J Vet Med Sci 59 133-136 (1997)
  68. Detecting small changes and additional peptides in the canine parvovirus capsid structure. Nelson CD, Minkkinen E, Bergkvist M, Hoelzer K, Fisher M, Bothner B, Parrish CR. J Virol 82 10397-10407 (2008)
  69. Modeling virus self-assembly pathways: avoiding dynamics using geometric constraint decomposition. Sitharam M, Agbandje-McKenna M. J Comput Biol 13 1232-1265 (2006)
  70. Expansion of tropism of a feline parvovirus to target a human tumor cell line by display of an alpha(v) integrin binding peptide on the capsid. Maxwell IH, Chapman JT, Scherrer LC, Spitzer AL, Leptihn S, Maxwell F, Corsini JA. Gene Ther 8 324-331 (2001)
  71. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages. Callaway HM, Feng KH, Lee DW, Allison AB, Pinard M, McKenna R, Agbandje-McKenna M, Hafenstein S, Parrish CR. J Virol 91 e01871-16 (2017)
  72. Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4. Kaludov N, Padron E, Govindasamy L, McKenna R, Chiorini JA, Agbandje-McKenna M. Virology 306 1-6 (2003)
  73. Structure of Bombyx mori densovirus 1, a silkworm pathogen. Kaufmann B, El-Far M, Plevka P, Bowman VD, Li Y, Tijssen P, Rossmann MG. J Virol 85 4691-4697 (2011)
  74. Epidemiological evolution of canine parvovirus in the Portuguese domestic dog population. Miranda C, Parrish CR, Thompson G. Vet Microbiol 183 37-42 (2016)
  75. Establishment of a rescue system for an autonomous Parvovirus mink enteritis virus. Yuan D, Wang J, Li Z, Mao Y, Sun JZ, Xi J, Wang S, Hou Q, Yi B, Liu W. Virus Res 183 1-5 (2014)
  76. Phylodynamic and Genetic Diversity of Canine Parvovirus Type 2c in Taiwan. Lin YC, Chiang SY, Wu HY, Lin JH, Chiou MT, Liu HF, Lin CN. Int J Mol Sci 18 E2703 (2017)
  77. Epitope mapping of Aleutian mink disease parvovirus virion protein VP1 and 2. Costello F, Steenfos N, Jensen KT, Christensen J, Gottschalck E, Holm A, Aasted B. Scand J Immunol 49 347-354 (1999)
  78. Genetic characterization of canine parvovirus type 2 subtypes in Maputo, Mozambique. Figueiredo J, Miranda C, Souto R, Silva E, Fafetine J, Thompson G. Arch Microbiol 199 543-549 (2017)
  79. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. Kawase M, Momoeda M, Young NS, Kajigaya S. J Virol 69 6567-6571 (1995)
  80. Structural tolerance versus functional intolerance to mutation of hydrophobic core residues surrounding cavities in a parvovirus capsid. Carreira A, Mateu MG. J Mol Biol 360 1081-1093 (2006)
  81. Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles. Gilbert L, Toivola J, Välilehto O, Saloniemi T, Cunningham C, White D, Mäkelä AR, Korhonen E, Vuento M, Oker-Blom C. J Nanobiotechnology 4 13 (2006)
  82. Effect of a valine residue at codon 352 of the VP2 capsid protein on in vivo replication and pathogenesis of Aleutian disease parvovirus in mink. Stevenson MA, Fox JM, Wolfinbarger JB, Bloom ME. Am J Vet Res 62 1658-1663 (2001)
  83. Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton. Lyi SM, Tan MJ, Parrish CR. Virology 456-457 342-352 (2014)
  84. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses. Pan Q, He K, Wang Y, Wang X, Ouyang W. Virus Genes 46 465-472 (2013)
  85. Sphingomyelin induces structural alteration in canine parvovirus capsid. Pakkanen K, Karttunen J, Virtanen S, Vuento M. Virus Res 132 187-191 (2008)
  86. Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology. Mietzsch M, McKenna R, Väisänen E, Yu JC, Ilyas M, Hull JA, Kurian J, Smith JK, Chipman P, Lasanajak Y, Smith D, Söderlund-Venermo M, Agbandje-McKenna M. Viruses 12 E653 (2020)
  87. Development of a recombinase polymerase amplification assay with lateral flow dipstick for rapid detection of feline parvovirus. Wang ZH, Wang XJ, Hou SH. J Virol Methods 271 113679 (2019)
  88. High-resolution asymmetric structure of a Fab-virus complex reveals overlap with the receptor binding site. Goetschius DJ, Hartmann SR, Organtini LJ, Callaway H, Huang K, Bator CM, Ashley RE, Makhov AM, Conway JF, Parrish CR, Hafenstein SL. Proc Natl Acad Sci U S A 118 e2025452118 (2021)
  89. Evidence of CPV2c introgression into Croatia and novel insights into phylogeny and cell tropism. Novosel D, Tuboly T, Balka G, Szeredi L, Lojkic I, Jungic A, Acinger-Rogic Z, Ait-Ali T, Csagola A. Sci Rep 9 16909 (2019)
  90. Molecular characterization of carnivore protoparvovirus 1 circulating in domestic carnivores in Egypt. Ndiana LA, Lanave G, Zarea AAK, Desario C, Odigie EA, Ehab FA, Capozza P, Greco G, Buonavoglia C, Decaro N. Front Vet Sci 9 932247 (2022)
  91. Watching one's P's and Q's: promiscuity, plasticity, and quasiequivalence in a T = 1 virus. Chapman MS. Biophys J 74 639-644 (1998)
  92. Cryo EM structures map a post vaccination polyclonal antibody response to canine parvovirus. Hartmann SR, Charnesky AJ, Früh SP, López-Astacio RA, Weichert WS, DiNunno N, Cho SH, Bator CM, Parrish CR, Hafenstein SL. Commun Biol 6 955 (2023)
  93. Isolation, cloning and analysis of parvovirus-specific canine antibodies from peripheral blood B cells. Früh SP, Adu OF, López-Astacio RA, Weichert WS, Wasik BR, Parrish CR. Dev Comp Immunol 147 104894 (2023)
  94. Molecular diversity of the VP2 of Carnivore protoparvovirus 1 (CPV-2) of fecal samples from Bogotá. Galvis CC, Jimenez-Villegas T, Reyes Romero DP, Velandia A, Taniwaki S, Oliveira de Souza Silva S, Brandão P, Santana-Clavijo NF. J Vet Sci 23 e14 (2022)


Related citations provided by authors (6)

  1. Determination and Refinement of the Canine Parvovirus Empty Capsid Structure. Wu H, Keller W, Rossmann MG To be Published -
  2. The Canine Parvovirus Empty Capsid Structure. Wu H, Rossmann MG J. Mol. Biol. 233 231- (1993)
  3. Structure determination of monoclinic canine parvovirus.. Tsao J, Chapman MS, Wu H, Agbandje M, Keller W, Rossmann MG Acta Crystallogr B 48 ( Pt 1) 75-88 (1992)
  4. Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones.. Parrish CR Virology 183 195-205 (1991)
  5. The Three-Dimensional Structure of Canine Parvovirus and its Functional Implications. Tsao J, Chapman MS, Agbandje M, Keller W, Smith K, Wu H, Luo M, Smith TJ, Rossmann MG, Compans RW, Parrish CR Science 251 1456- (1991)
  6. Preliminary X-ray crystallographic analysis of canine parvovirus crystals.. Luo M, Tsao J, Rossmann MG, Basak S, Compans RW J Mol Biol 200 209-11 (1988)

Quick links